Anebulo Pharmaceuticals, Inc.

ANEB

Financials

10-QQ2 ended 12/31/2502/12/26 10-QQ1 ended 09/30/2511/13/25 10-KFY 202509/29/25 10-QQ3 ended 03/31/2505/13/25 10-QQ2 ended 12/31/2402/14/25

Disclosures

8-KCurrent report02/12/26 8-KCurrent report02/06/26 8-KCurrent report01/29/26 8-KCurrent report01/27/26 8-KCurrent report12/22/25

Prospectuses and Registrations

S-8 POSPost-effective amendment (S-8)09/26/25 S-8 POSPost-effective amendment (S-8)09/26/25 POS AMPost-effective amendment09/19/25 POS AMPost-effective amendment09/19/25 S-8Registration of securities for employees05/15/25

Proxies

PRER14APreliminary proxy (revised)10/10/25 PRER14APreliminary proxy (revised)09/15/25 PRE 14APreliminary proxy07/23/25 DEF 14ADefinitive proxy03/06/25 PRE 14APreliminary proxy02/24/25

Ownership

SC 13G/ABeneficial ownership (amended)02/13/26 Form 4Insider transaction04/07/25 Form 4Insider transaction04/07/25 Form 4Insider transaction04/07/25 Form 4Insider transaction04/07/25

Other

15-12GCertification of termination of registration03/02/26 25Removal from listing02/17/26 SC 13E3/ASC 13E3/A01/29/26 SC 13E3/ASC 13E3/A01/27/26 CORRESPCorrespondence with the SEC01/08/26